Mavis Boakye-Yiadom

Dr. Mavis Boakye-Yiadom


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in Heliyon
Verified
Journal Article
Open access
DKDoris Kumadoh
Doris Kumadoh
MAMary-Ann Archer
Mary-Ann Archer
GYGenevieve N. Yeboah
Genevieve N. Yeboah
MKMichael O. Kyene
Michael O. Kyene
MBMavis Boakye-Yiadom
Mavis Boakye-Yiadom
SMSusana O. Mintah
Susana O. Mintah
Peptic ulcer disease affects many people globally. With the increasing resistance to some orthodox antibiotics such as Clarithromycin and Metronidazole, it is important that new acceptable, safer and effective therapies are developed to manage this disease. Various herbal medicines have been used traditionally for the remedy of peptic ulcer disease (PUD), however scientific information with regards to their anti-peptic ulcer both in-vivo and in-vitro as well as clinical studies supporting their use is still inadequate. The Centre for Plant Medicine Research, (CPMR) Mampong-Akuapem, Ghana manufactures three herbal Products namely Enterica, Dyspepsia and NPK 500 capsules which are currently used for the remedy of PUD as a triple therapy at its out-patient clinic with promising effects. The aim of this review is to gather information from literature on the anti-ulcer properties, pharmacological, phytochemical constituents and related activities of herbal plants used at the CPMR for formulation of the triple herbal therapy. This review may, provide some scientific bases for the use of Enterica, Dyspepsia and NPK 500 capsules in the management of Peptic ulcer at the CPMR out-patient clinic. Organization for the review involved the on and/or offline search for information from available literature using electronic data and scientific research information resources such as PubMed, Science Direct and Google scholar. In this review, fifteen ethno-medicinal plants used for the formulation of Enterica, Dyspepsia and NPK capsules have been discussed, presenting the description of the plants, composition and pharmacological activity. Tables with the summary of reviewed medicinal plants with their anti-ulcer models and inference on possible mechanisms of action were drawn up. The mechanism(s) of action of individual plants and products (Enterica, Dyspepsia and NPK 500 capsules) must be further investigated and established experimentally in-vitro in addition to in-vivo pharmacological and clinical activity studies to confirm their use in the remedy of PUD.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MBMavis Boakye-Yiadom
Mavis Boakye-Yiadom
DKDoris Kumadoh
Doris Kumadoh
Emmanuel AdaseEmmanuel Adase
Emmanuel Adase
EWEric Woode
Eric Woode
Background. The growth or multiplication of harmful microorganisms in addition to harmful human activities has led to many disorders in humans. Consequently, there is a search for medications to treat these disorders. Interestingly, medicines of plant origin are known to be among the most attractive sources of new drugs and have shown promising results in the treatment of various diseases including peptic ulcers. This review, therefore, is aimed at obtaining knowledge on some Ghanaian ethnomedicinal plants used to treat peptic ulcers, their folkloric uses, their phytochemicals, and their antiulcer and related pharmacological activities as well as finding areas for prospective studies.Methods. Published peer‐reviewed articles on ethnomedicinal plants used for the management of peptic ulcers in Ghana from 1967 to 2020 were sourced and used for the study. Results. In this review, 13 plants were identified which belong to 10 different families including Sapindaceae, Apocynaceae, and Bignoniaceae. The parts most often used for most preparations were the leaves (53%), followed by stem bark and roots (both having the same percentage of use of 17.6%), the whole plant (5.9%), and the rhizomes (5.9%). Azadirachta indica was the only plant that had undergone some patient studies in addition to animal studies. Conclusion. A discussion of various antiulcer activity studies using ulcer models carried out on selected medicinal plants used for the management of peptic ulcer disease in addition to brief information on their folkloric uses and their phytochemical and other pharmacological properties is presented. These medicinal plants may be used in developing herbal products for the management of peptic ulcer disease.

24 July 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SAS. Antwi
S. Antwi
JAJ. Asiedu-Larbi
J. Asiedu-Larbi
OMO. N. K. Martey
O. N. K. Martey
OQO. Quasie
O. Quasie
MBMavis Boakye-Yiadom
Mavis Boakye-Yiadom
AOA. Ocloo
A. Ocloo
Mist Antiaris is a herbal decoction for treatment of nervous disorders. Safety and efficacy were evaluated in Sprague-Dawley rats and human patients, respectively. Acute toxicity was assessed by administration of a single 5000 mg/kg oral dose of decoction to a group of six rats. For subchronic toxicity, four groups of six rats each received water (control) or 10, 100, or 200 mg/kg oral doses of decoction daily for eight weeks. Body weight, serum, urine, and hematological profile of the animals in each group were monitored over the period. Effects of treatment on pentobarbital-induced sleeping time and histology of liver, lung, heart, and kidney tissue were assessed at the end of the study. There was no evidence of acute toxicity within 48 hours of the oral dose. Over the 8-week period, body weight increases in Mist Antiaris treatment groups were reduced relative to the control group. There were no significant differences in urine profile, serum biochemistry, hematological parameters, and pentobarbital-induced sleeping time. Tissue histology revealed no differences relative to controls. Assessment of efficacy was by retrospective review of data on patients who presented with peripheral neuropathy. Treatment resulted in 53.7 % of patients reporting complete resolution and 15.7 % showing reduction in neuropathic symptoms. The data demonstrate that there is no toxicity due to subchronic administration of Mist Antiaris in Sprague-Dawley rats. The reduction or resolution of neuropathic symptoms indicated by patents’ file data provides evidence to suggest that Mist Antiaris has antineuropathic effects.

7 January 2025 in Diabetology
Verified
Journal Article
Open access
PDF file
Collins Afriyie AppiahCollins Afriyie Appiah
Collins Afriyie Appiah
JNJennifer Ngounda
Jennifer Ngounda
MBMavis Boakye-Yiadom
Mavis Boakye-Yiadom
FMFelix Charles Mills-Robertson
Felix Charles Mills-Robertson
MNMariette Nel
Mariette Nel
CWCorinna Walsh
Corinna Walsh
Background: It is well-known that persistent hyperglycaemia predisposes individuals with diabetes to oxidative stress. Bridelia ferruginea Benth., a tropical African plant, is known for its antioxidant activity. Methods: This comparative cross-sectional study assessed the oxidative status and associated parameters in 70 individuals living with type 2 diabetes (ILWT2D) who were receiving standard diabetes treatment and consistently drank Bridelia tea (Bridelia group) compared to 92 ILWT2D receiving standard diabetes treatment only (comparator group). Lipid peroxidation assessed using thiobarbituric acid reactive substances (TBARS) served as an indicator of oxidative stress. In addition, the total antioxidant capacity (TAC), glycated haemoglobin (HbA1c), and dietary intake of antioxidant-rich foods were assessed. Results: The comparator group had significantly better glycaemic control [median HbA1c—7.7% (IQR 6.7–9.4)] than the Bridelia group [9.2% (7.6–11.4)], p = 0.001. The comparator group had been on metformin treatment for a significantly longer period than the Bridelia group (p < 0.0001). Participants in the comparator group consumed antioxidant-rich fruits more frequently (monthly basis) than those in the Bridelia group who ate fruits seldomly (p < 0.0001). There was no significant difference (p = 0.11) observed in oxidative stress levels between the Bridelia group and the comparator group [TBARS: 323.0 ng/L (287.5–374.0) and 317.0 ng/L (272.5–342.0), respectively]. Nonetheless, the Bridelia group had significantly higher antioxidant capacity (p = 0.001) compared to the comparator group [TAC: 1.01 mmol/L (0.93–1.10) versus 0.92 mmol/L (0.84–1.03), respectively]. Participants in the comparator group, who did not drink Bridelia tea, had been on longer metformin treatment with better glycaemic control. However, those who drank the Bridelia tea showed comparable levels of oxidative stress and exhibited elevated antioxidant levels compared to those who did not. Conclusions: Bridelia tea consumption may serve as a sustainable source of antioxidants; however, its effect on mitigating oxidative stress in ILWT2D requires further investigation, particularly given that no significant improvement in TBARS was observed. Future studies are needed to clarify the potential role of Bridelia tea in oxidative stress management in resource-limited settings like Ghana.

23 February 2024 in Clinical Case Reports
Verified
Journal Article
Open access
MBMavis Boakye-Yiadom
Mavis Boakye-Yiadom
RYRonald Yeboah
Ronald Yeboah
DODavid Offei‐Abrokwa
David Offei‐Abrokwa
EWEkuwa Baisiwa Wilson
Ekuwa Baisiwa Wilson
SDSamuel Annang Darko
Samuel Annang Darko
ETEmmanuel Tamakloe
Emmanuel Tamakloe
Key Clinical Message: Nibima and Immunim manages mild COVID‐19 in 7 days. Coronavirus Disease 2019 (COVID‐19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) can lead to severe complications and deaths. The search for phytotherapeutic agents to augment the fight against the current COVID‐19 pandemic is therefore of highest priority. A 52‐year‐old female with no history of chronic illness presented to our clinic facility with a 3 days loss of smell and headache which persisted after self‐medication. The patient tested positive for COVID‐19 in the SARS‐CoV‐2 Ag test as well as the Typhoid rapid antibody test. Routine laboratory tests were not remarkable. A 60 mL three times daily dose of Nibima and 5 mL in 40 mL of warm water dose of Immunim were given to the patient for 7 days. Patient recovered sense of smell and regained appetite but cough although reduced persisted. She also tested negative for COVID‐19 after 7 days treatment. This case is the first documented case of COVID‐19 management with herbal medicines in Ghana. We strongly suggest a larger control trial on these products to ascertain these findings to repurpose them as viable treatments for COVID‐19.